SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-265691
Filing Date
2023-10-30
Accepted
2023-10-30 08:05:53
Documents
13
Period of Report
2023-10-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d575905d8k.htm   iXBRL 8-K 30300
2 EX-2.1 d575905dex21.htm EX-2.1 135305
  Complete submission text file 0001193125-23-265691.txt   323676

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA blue-20231026.xsd EX-101.SCH 2863
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE blue-20231026_lab.xml EX-101.LAB 17236
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE blue-20231026_pre.xml EX-101.PRE 10821
7 EXTRACTED XBRL INSTANCE DOCUMENT d575905d8k_htm.xml XML 3230
Mailing Address 455 GRAND UNION BOULEVARD SOMERVILLE MA 02145
Business Address 455 GRAND UNION BOULEVARD SOMERVILLE MA 02145 339-499-9300
bluebird bio, Inc. (Filer) CIK: 0001293971 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35966 | Film No.: 231357277
SIC: 2836 Biological Products, (No Diagnostic Substances)